Citations

Showing 10 of 108162 citations.

The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial
Wood, Marie , Liu, Heshan , Storrick, Elizabeth, Zahrieh, David , Le-Petross, H. Carisa , Zekan, Patricia J., Kemeny, Margaret, Charlamb, Jayne R. , Wang, Lili X, Unzeitig, Gary, Johnson, Candace S. , Marshall, James R. , Charlamb, Jayne R , Johnson, Candace S , Garber, J. E. , Le‐Petross, Huong T. , Jung, Sin‐Ho , Garber, Judy E. , Bedrosian, Isabelle

Mayo Clinic

Cancer Prevention Research | April 13, 2021 | Volume: 14 | Issue: 7 | Pages: 753-762

10.1158/1940-6207.capr-20-0581 | PMID 33849913 Get It

Abstract Current therapies for breast cancer prevention only prevent estrogen receptor positive (ER+) disease and toxicity limits use of these agents. Vitamin D is a potential prevention therapy for both ER+ and ER− disease and is safe with few side effects. This study evaluates the effect of 1-year of vitamin D supplementation on mammographic density (MD), a biomarker of breast cancer risk in a multicenter randomized controlled trial. Premenopausal women with ≥25% MD and no history of cancer were randomly assigned to 2,000 international units (IU) of vitamin D or placebo orally daily for 1 year. Change in percent MD was evaluated using Cumulus software after all participants completed treatment. Three hundred women enrolled between January 2011 and December 2013 with a mean age of 43 and diverse ethnicity [14% Hispanic, 12% African American (AA)]. Supplementation significantly increased vitamin D levels compared with placebo (14.5 ng/mL vs. −1.6 ng/mL; P < 0.0001) with all participants on the vitamin D arm achieving vitamin D sufficiency at 12 months. Vitamin D was safe and well tolerated. After adjustment for baseline MD, the mean between-arm difference (vitamin D vs. placebo) at 1 year was −0.75 (−0.26, 1.76; P = 0.56). A greater effect was seen for women with ≥50% MD and AA women, although neither reached significance. This randomized controlled trial demonstrated significant improvement in vitamin D levels with 2,000 IU for 1 year, with 100% of supplemented women achieving sufficiency. However, a null effect was seen regarding change in MD for premenopausal women (the primary outcome of the study). Prevention Relevance: Current therapies for breast cancer prevention only prevent estrogen receptor positive (ER+) disease and are underutilized due to toxicity and side effects. Vitamin D is a potential prevention therapy for both ER+ and ER− disease and is safe with few side effects.
Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging Substudy
Rettmann, Maryam E. , Holmes, David R. , Monahan, Kristi H. , Breen, Jerome F., Bahnson, Tristram D. , Mark, Daniel B. , Poole, Jeanne E. , Ellis, Alicia M. , Silverstein, A , Al‐Khalidi, Hussein R. , Lee, Kerry L., Robb, Richard A., Packer, Douglas L. , Investigators, for the CABANA Imaging, Silverstein, Adam P , Mark, Daniel B , Investigators, for the CABANA Imaging

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | April 13, 2021 | Volume: 14 | Issue: 5 | Pages: No page available

10.1161/circep.120.008540 | PMID 33848199 Get It

Background: The CABANA trial (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) was a randomized, prospective trial of left atrial catheter ablation versus drug therapy for treatment of atrial fibrillation (AF). As part of CABANA, a prospective imaging substudy was conducted. The main objectives were to describe the patterns of changes in the dimensions of the left atrium and pulmonary veins (PVs), and the relationship between these changes with treatment assignment and clinical outcomes. Methods: Computed tomography or magnetic resonance imaging was acquired at baseline and follow-up in 121 ablation (median follow-up 101 days) and 85 drug patients (median follow-up 97 days). Left atrial volume index, mean PV ostial diameter, and ostial diameters of each PV separately were computed. We examined the relationship between the change from baseline to follow-up with subsequent clinical outcomes (composite of death, disabling stroke, serious bleeding, or cardiac arrest [CABANA primary end point], total mortality or cardiovascular hospitalization, first AF recurrence after the 90-day blanking period, first AF/atrial flutter/atrial tachycardia after the 90-day blanking period) using Cox proportional-hazards models. Results: The median (25th to 75th) change from baseline for left atrial volume index was −7.8 mL/m 2 (−16.4 to 0.2), ablation arm and −3.5 mL/m 2 (−11.4 to 2.6), drug therapy arm. The left atrial volume index decreased in 52.9% of ablation patients versus 40.0% of drug therapy patients. Change for mean PV was −2.7 mm (−4.2 to −1.3) in the ablation arm versus −0.1 mm (−1.5 to 0.8) in the drug therapy arm. Changes in left atrium and PV dimensions had no consistent relationship with the risk of developing the study primary end point. Reductions in left atrial volume index, and in mean PV diameter were associated with decreased risk of AF recurrence. Conclusions: Ablation patients demonstrated more frequent and larger atrial structural changes compared with drug patients. These changes suggest a critical relationship between structural features and AF generation.
Correlation of older age with severity of lymphedema in breast cancer survivors: A systematic review
Guliyeva, Günel , Huayllani, María T. , Forte, Antonio J. , Boczar, Daniel , Ávila, Francisco R. , Forte, Antonio Jorge

Mayo Clinic

Breast Disease | April 13, 2021 | Volume: 40 | Issue: 3 | Pages: 191-197

10.3233/bd-201067 | PMID 33867353 Get It

BACKGROUND: Breast cancer is the most frequent cause of secondary lymphedema. Besides being progressive and chronic, lymphedema is usually hard to treat. That is why the clinicians are more focused on the prevention of its development and progression. OBJECTIVE: The aim of this study is to evaluate the possible relationship between the age of patients and the severity of breast cancer-related lymphedema (BCRL). METHODS: PubMed, Scopus, and Ovid MEDLINE databases were searched for articles, which described the relationship between aging and BCRL development. Two authors searched for and selected articles independently. RESULTS: Out of 562 studies selected, 8 studies met the inclusion criteria. However, 2 papers had the same study population, so only 7 were included in the final analysis. The total number of patients in those 7 studies was 3,904. Five out of 7 studies included in our review depicted the association of more severe forms of BCRL with older age. CONCLUSION: The final analysis showed that aging is related to the severity of BCRL. However, due to heterogeneity in study outcome reporting, the cause and effect relationship could not be determined.
Rare presentation of subglottic soft-tissue swelling following FOLFOX therapy in a patient with metastatic oesophageal cancer
Yarrarapu, Siva Naga S. , Govero, Austin B, KUKHON, FAEQ R , Sanghavi, Devang , Sanghavi, Devang K., Yarrarapu, Siva Naga S , Govero, Austin

Mayo Clinic

BMJ Case Reports | April 13, 2021 | Volume: 14 | Issue: 4 | Pages: e240938

10.1136/bcr-2020-240938 | PMID 33849874 Get It

Oesophageal cancer is categorised among the most fatal cancers across the world with a mortality ranking of sixth position. Chemotherapy with FOLFOX—a regimen of fluorouracil, leucovorin, and oxaliplatin—has been approved in the treatment of oesophageal cancer owing to its lower toxicity compared with the previous regimens. We report the first case of a patient with oesophageal cancer metastatic to the hyoid presenting with sudden-onset shortness of breath and anterior neck swelling secondary to treatment with FOLFOX-6. CT was notable for subglottic soft-tissue swelling and cystic necrosis of the hyoid bone tumour, and the patient subsequently required placement of a definitive airway via tracheostomy. This case illustrates the importance of anticipating the need for pre-emptive tracheostomy in patients with hyoid bone tumours receiving treatment with FOLFOX.
COVID-19 Impact on Interventional Pulmonology Training
Kalchiem‐Dekel, Or , Schwalk, Audra, Patel, Niral M. , Lin, I‐Hsin , Beattie, Jason , Husta, Bryan , Chawla, Mohit , Sachdeva, Ashutosh , Akulian, Jason , Musani, Ali I., Argento, A. Christine , Lee, Hans J. , Mullon, John J., Desai, Neeraj, Lee, Robert P. , Hsia, David W.

Mayo Clinic

ATS Scholar | April 13, 2021 | Volume: 2 | Issue: 2 | Pages: 236-248

10.34197/ats-scholar.2020-0126oc | PMID 34409418 Get It

Abstract Background The impact of the coronavirus disease (COVID-19) pandemic extends beyond the realms of patient care and healthcare resource use to include medical education; however, the repercussions of COVID-19 on the quality of training and trainee perceptions have yet to be explored. Objective The purpose of this study was to determine the degree of interventional pulmonology (IP) fellows’ involvement in the care of COVID-19 and its impact on fellows’ clinical education, procedure skills, and postgraduation employment search. Methods An internet-based survey was validated and distributed among IP fellows in North American fellowship training programs. Results Of 40 eligible fellows, 38 (95%) completed the survey. A majority of fellows (76%) reported involvement in the care of patients with COVID-19. Fellows training in the Northeast United States reported involvement in the care of a higher number of patients with COVID-19 than in other regions (median, 30 [interquartile range, 20–50] vs. 10 [5–13], respectively; P < 0.01). Fifty-two percent of fellows reported redeployment outside IP during COVID-19, mostly into intensive care units. IP procedure volume decreased by 21% during COVID-19 compared with pre–COVID-19 volume. This decrease was mainly accounted for by a reduction in bronchoscopies. A majority of fellows (82%) reported retainment of outpatient clinics during COVID-19 with the transition from face-to-face to telehealth-predominant format. Continuation of academic and research activities during COVID-19 was reported by 86% and 82% of fellows, respectively. After graduation, all fellows reported having secured employment positions. Conclusion Although IP fellows were extensively involved in the care of patients with COVID-19, most IP programs retained educational activities through the COVID-19 outbreak. The impact of the decrease in procedure volume on trainee competency would be best addressed individually within each training program. These data may assist in focusing efforts regarding the education of medical trainees during the current and future healthcare crises.
Roundtable Discussion: COVID-19 and Obesity—Implications and Integrative Management
Kushner, Robert F. , Frates, Beth, Hensrud, Donald D. , HART, JANE K. , Katz, David L.

Mayo Clinic

Alternative and Complementary Therapies | April 13, 2021 | Volume: 27 | Issue: 2 | Pages: 57-63

10.1089/act.2021.29318.dlk Get It

Cell-Mediated Therapies to Facilitate Operational Tolerance in Liver Transplantation
Ellias, Samia D., Larson, Ellen L. , Taner, Timuçin , Nyberg, Scott L. , Taner, Timucin , Nyberg, Scott L , Larson, Ellen L , Ellias, Samia D.

Mayo Clinic

International Journal of Molecular Sciences | April 13, 2021 | Volume: 22 | Issue: 8 | Pages: 4016

10.3390/ijms22084016 | PMID 33924646 Get It

Cell therapies using immune cells or non-parenchymal cells of the liver have emerged as potential treatments to facilitate immunosuppression withdrawal and to induce operational tolerance in liver transplant (LT) recipients. Recent pre-clinical and clinical trials of cellular therapies including regulatory T cells, regulatory dendritic cells, and mesenchymal cells have shown promising results. Here we briefly summarize current concepts of cellular therapy for induction of operational tolerance in LT recipients.
The Interplay of SARS-CoV-2 and Clostridioides Difficile Infection
Khanna, Sahil , Kraft, Colleen S.

Mayo Clinic

Future Microbiology | April 13, 2021 | Volume: 16 | Issue: 6 | Pages: 439-443

10.2217/fmb-2020-0275 | PMID 33847139 Get It

A standard system phantom for magnetic resonance imaging
Stupic, Karl F. , Ainslie, Maureen, Boss, Michael A. , Charles, Cecil, Dienstfrey, Andrew , Evelhoch, Jeffrey L., Finn, Paul, Gimbutas, Zydrunas , Gunter, Jeffrey L. , Hill, David , Karaulanov, Todor , Liu, Guoying , Martin, Michele N. , Prasad, Pottumarthi V. , Rentz, Nikki S., Yuan, Chun , Keenan, Kathryn E , Yuan, Chun , Russek, Stephen E , Boss, Michael A , Jack, Clifford R. , Jackson, Edward F. , Keenan, Kathryn E. , Russek, Stephen E.

Mayo Clinic

Magnetic Resonance in Medicine | April 13, 2021 | Volume: 86 | Issue: 3 | Pages: 1194-1211

10.1002/mrm.28779 | PMID 33847012 Get It

Purpose A standard MRI system phantom has been designed and fabricated to assess scanner performance, stability, comparability and assess the accuracy of quantitative relaxation time imaging. The phantom is unique in having traceability to the International System of Units, a high level of precision, and monitoring by a national metrology institute. Here, we describe the phantom design, construction, imaging protocols, and measurement of geometric distortion, resolution, slice profile, signal‐to‐noise ratio (SNR), proton‐spin relaxation times, image uniformity and proton density. Methods The system phantom, designed by the International Society of Magnetic Resonance in Medicine ad hoc committee on Standards for Quantitative MR, is a 200 mm spherical structure that contains a 57‐element fiducial array; two relaxation time arrays; a proton density/SNR array; resolution and slice‐profile insets. Standard imaging protocols are presented, which provide rapid assessment of geometric distortion, image uniformity, T 1 and T 2 mapping, image resolution, slice profile, and SNR. Results Fiducial array analysis gives assessment of intrinsic geometric distortions, which can vary considerably between scanners and correction techniques. This analysis also measures scanner/coil image uniformity, spatial calibration accuracy, and local volume distortion. An advanced resolution analysis gives both scanner and protocol contributions. SNR analysis gives both temporal and spatial contributions. Conclusions A standard system phantom is useful for characterization of scanner performance, monitoring a scanner over time, and to compare different scanners. This type of calibration structure is useful for quality assurance, benchmarking quantitative MRI protocols, and to transition MRI from a qualitative imaging technique to a precise metrology with documented accuracy and uncertainty.